BioNote IPO Valuation Analysis
Our base case valuation is target price of 16,182 won per share, which is 10% lower than the low end of the IPO price range.
374 Views
BioNote IPO Preview
BioNote, a Korean company specializing in bio contents and animal diagnostics, is getting ready for an IPO in November. The IPO offering amount is...
318 Views